Mats Blom
Tracked across 1 events · 7 articles · First seen Sep 14, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Avacta Group Therapeutics, a clinical-stage biopharmaceutical company listed on AIM under ticker AVCT, announced on September 14, 2026 the appointment of seasoned biotechnology finance executive Mats Blom to its Board of Directors as a non-executive…
Impact: Appointed as non-executive director and Audit Committee Chair of Avacta Group, bringing extensive biotech CFO and board experience to the role.
Sep 14, 2026 · 7 articles
80
Avacta Group appointed Mats BlomAvacta Appoints Mats Blom...
ERGEN INTELLIGENCE
Track Mats Blom live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard